8-KLeadership ChangesExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Executive Changes (Apr 9, 2021)

Filed April 9, 2021For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) announced on April 9, 2021, the adoption of its 2021 Senior Officer Performance Excellence Program (Senior Officer PEP). This program outlines the performance-based compensation structure for the company's executive officers, including named executive officers. The program aims to align executive compensation with key financial and operational objectives, emphasizing both financial performance and quality of care. The Senior Officer PEP allocates 80% of potential awards to the achievement of EBITDA targets and 20% to the achievement of specified quality metrics. For certain group presidents, the EBITDA component is further divided between company-wide EBITDA and their respective group's EBITDA. The quality metrics encompass Healthcare-Associated Infections, Core Measures, CHOIS Risk-Adjusted Indices, and Care Experience. Payouts are in cash and are subject to threshold performance levels, with opportunities for enhanced payouts up to 200% of target for exceeding performance expectations.

Key Highlights

  • 1HCA Healthcare has implemented the 2021 Senior Officer Performance Excellence Program (Senior Officer PEP) to structure executive compensation.
  • 2The program bases executive awards 80% on EBITDA targets and 20% on quality metrics.
  • 3For American Group and National Group Presidents, the EBITDA component is split 50% company EBITDA and 50% group EBITDA.
  • 4Quality metrics include Healthcare-Associated Infections, Core Measures, CHOIS Risk-Adjusted Indices, and Care Experience.
  • 5CEO Samuel N. Hazen has the highest target award opportunity at 170% of base salary.
  • 6The program allows for payouts ranging from 25% of target award for threshold performance to 200% for maximum performance on the EBITDA component, and similar tiered payouts for quality metrics.
  • 7Awards are paid in cash and are subject to clawback or adjustment provisions under certain circumstances, including restatements or misconduct.

Frequently Asked Questions

The primary purpose of the 2021 Senior Officer PEP is to align the compensation of HCA Healthcare's senior executives with the achievement of specific financial and quality performance targets, thereby incentivizing them to drive company growth and maintain high standards of care.

Executive compensation is determined based on a weighted formula: 80% is tied to the achievement of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) targets, and 20% is linked to meeting defined quality metrics related to patient care.

Yes, payouts are contingent on meeting minimum threshold performance levels. Additionally, the program includes provisions for clawbacks or adjustments if operating results are restated, or in cases of participant misconduct. A critical condition for any quality-based payout is that the company's actual EBITDA must be at least 90% of the target EBITDA.

For the EBITDA-weighted portion, payouts can range from 25% of the target award for threshold performance up to 200% for maximum performance. Similarly, for the quality-weighted portion, payouts can range from 0% (below threshold) up to 200% of the target award for maximum performance in each quality category, provided the company meets the minimum EBITDA threshold.